Effects of high volume saline enemas vs no enema during labour – The N-Ma Randomised Controlled Trial [ISRCTN43153145] by Bernal María et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Pregnancy and Childbirth
Open Access Research article
Effects of high volume saline enemas vs no enema during labour – 
The N-Ma Randomised Controlled Trial [ISRCTN43153145]
Luis Gabriel Cuervo*1, María del Pilar Bernal2 and Natalia Mendoza3
Address: 1Universidad Javeriana, Clinical Epidemiology Research and Training Center, Colombia, 2Portland, OR, USA and 3División de 
Investigaciones, Universidad El Bosque, Bogotá D.C., Colombia
Email: Luis Gabriel Cuervo* - lgcuervo@gmail.com; María del Pilar Bernal - mapilarbernal@msn.com; Natalia Mendoza - natyt99@yahoo.com
* Corresponding author    
Abstract
Background: Enemas are used during labour in obstetric settings with the belief that they reduce
puerperal and neonatal infections, shorten labour duration, and make delivery cleaner for attending
personnel. However, a systematic review of the literature found insufficient evidence to support the use
of enemas. The objective of this RCT was to address an identified knowledge gap by determining the effect
of routine enemas used during the first stage of labour on puerperal and neonatal infection rates.
Methods: Design: RCT (randomised controlled trial; randomized clinical trial).
Outcomes:  Clinical diagnosis of maternal or neonatal infections, labour duration, delivery types,
episiotomy rates, and prescription of antibiotics
Setting: Tertiary care referral hospital at the Javeriana University (Bogotá, Colombia) that attended 3170
births during study period with a caesarean section rate of 26%.
Participants: 443 women admitted for delivery to the obstetrics service (February 1997 to February
1998) and followed for a month after delivery. Inclusion criteria were women with: low risk pregnancy and
expected to remain in Bogotá during follow up; gestational age ≥ 36 weeks; no pelvic or systemic bacterial
infection; intact membranes; cervix dilatation ≤7 cm.
Intervention: 1 litre saline enema, versus no enema, allocated following a block random allocation
sequence and using sealed opaque envelopes.
Results: Allocation provided balanced groups and 86% of the participants were followed up for one
month. The overall infection rate for newborns was 21%, and 18% for women. We found no significant
differences in puerperal or neonatal infection rates (Puerperal infection: 41/190 [22%] with enema v 26/
182 [14%] without enema; RR 0.66 CI 95%: 0.43 to 1.03; neonatal infection 38/191 [20%] with enema v
40/179 [22%] without enema; RR 1.12, 95% CI 95% 0.76 to 1.66), and median labour time was similar
between groups (515 min. with enema v 585 min. without enema; P = 0.24). Enemas didn't significantly
change episiorraphy dehiscence rates (21/182 [12%] with enema v 32/190 [17%] without enema; P = 0.30).
Conclusion: This RCT found no evidence to support routine use of enemas during labour. Although
these results cannot rule out a small clinical effect, it seems unlikely that enemas will improve maternal and
neonatal outcomes and provide an overall benefit.
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Background
Enemas are frequently used in obstetric settings because
they are thought to reduce the risk of puerperal and neo-
natal infections, shorten the duration of labour and make
delivery cleaner for attending personnel [1,2]. However,
the use of enemas is controversial and there is little evi-
dence of their effectiveness. Enemas are upsetting and
humiliating for women in labour and increase the work-
load in labour wards. Enemas cause watery stools and
could theoretically increase contamination and infection
rates[3,4].
A systematic review of the literature found one trial with
222 women, which found no difference in puerperal or
neonatal infections. However, it only followed women
while they remained hospitalized; this time may be too
short to identify outcomes that could be affected by ene-
mas. The review concluded that there was insufficient evi-
dence to recommend the use of enemas during labour and
called for additional RCTs [5].
The main objective of this RCT was to find out if the use
of high volume enemas during the first stage of labour
modified neonatal and puerperal infectious rates. The
null hypothesis stated that proportion of infections was
similar for the intervention and control groups. The sec-
ondary objectives were to establish if there was an effect
on specific neonatal or puerperal infectious rates, and
other clinically relevant outcomes such as neonatal infec-
tions, maternal pelvic inflammatory disease or suture
dehiscence, and antibiotic prescriptions. The protocol for
this study was presented and debated at two meetings of
the Latin American Clinical Epidemiology Network: Lat-
inclen I in April 1995 in Colombia; and the Latinclen III
in September 1997 in Dominican Republic.
Methods
The RCT was conducted at the obstetric service of the Hos-
pital Universitario San Ignacio, a tertiary care referral centre
in Bogota, Colombia. Women attending the admission
unit of the obstetrics' clinic for delivery were invited to
participate.
In accordance with the protocol, the examining intern or
resident would invite all eligible women to participate in
the study. Recruitment rates varied greatly among differ-
ent interns and residents. Because of the frequent rotation
of interns and residents through the admission unit,
interns and residents attended standardised monthly
training sessions on how to enrol patients on the study.
Inclusion criteria included: absence of life threatening
events at admission interview (such as placental abruptio,
prolapsed cord, or eclampsia); gestational age ≥36 weeks
based on the best available estimation such as a reliable
last menstrual period date or an appropriate ultrasound;
projected permanence in Bogota during the month fol-
lowing delivery; and willingness to participate expressed
in a written informed consent. There was no age restric-
tion for participants. However, for women under 18 years
of age, an adult witness – most frequently a next of kin,
was also asked to participate in the informed consent
process.
Exclusion criteria included: a clinical diagnosis of any sys-
temic or gynaecological bacterial infection; use of sys-
temic antibiotics during the week prior to admission;
rupture of amniotic membranes or uncertainty of their
integrity; or a cervical dilatation >7 cm.
The trial protocol was approved by the Institutional
Review Board of the Medical School of the Javeriana Uni-
versity and by the staff of the Clinical Epidemiology and
Biostatistics Unit.
Women willing to participate were offered a range of addi-
tional services during follow-up. These services were
designed to improve outcome detection and adherence to
the study. All women received a booklet that addressed
questions frequently raised by women during labour and
puerperium (30 days following delivery), and informed
on early signs for maternal and neonatal infections[6].
The development of the booklet involved semi-structured
interviews carried out by a trained nurse who would elicit
the issues that worried women during the first day, first
week and first month after delivery. The team that
designed the booklet included graphic designers and a
social communications specialist. The booklet was tested
and printed prior to the beginning of the RCT. Partici-
pants were offered two programmed health care visits
where their concerns could be discussed with a profes-
sional nurse. During the visits, the nurse examined the
mother and the baby and assessed outcomes. Systematic
telephone reminders for these visits were scheduled
before the 1st and 4th week after delivery. Women received
instructions on how to access a 24-hour paging service
which allowed them to contact a health care provider to
address any concerns, seek support, inform about prob-
lems, or get advice on issues such as emergency medical
attention. This allowed retrieving relevant information of
visits to other healthcare providers and contacting them to
collect data. The local branch of La Leche League Interna-
tional, a volunteer organization delivering support and
education on breastfeeding, offered regular free educa-
tional sessions for participants. All participants were
offered subsidised screening for neonatal hypothy-
roidism; when this RCT was done, screening for thyroid
disease was not mandatory nor covered by health mainte-
nance organisations in Colombia.BMC Pregnancy and Childbirth 2006, 6:8 http://www.biomedcentral.com/1471-2393/6/8
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Assignment and follow-up procedures
Randomisation was done in blocks of 2 (20%), 4 (60%)
and 6 (20%) using Ralloc® allocation software. Once the
participant had completed the informed consent process,
an opaque envelope with sequential numbering and
instructions was opened. Women randomised to the
intervention group received a 1 litre Travad® 2.5% sodium
chloride solution enemas applied by a nurse assistant
prior to been taken to the labour wards, where partici-
pants in both groups would thereafter receive the same
care.
During the first and third week after delivery, reminders to
attend scheduled appointments at the outpatient primary
care clinic were delivered by phone and mail. We used a
standardised telephone survey to assess if participants had
used any other health services or been diagnosed with any
particular condition. Newborns were screened for
hypothyroidism during the first scheduled visit when the
mother agreed to it. Results for the screening tests were
scheduled to be delivered at the second visit, but these
were also couriered with an explanatory note if the
appointment was missed. The screening scheme covered
confirmation diagnostic tests, when necessary.
The primary outcomes were the diagnosis of infections in
newborns or women during the month following deliv-
ery. A neonatal outcome was positive if during the first
month of life the child was prescribed systemic antibiot-
ics. A neonatal outcome was also positive when the child
was diagnosed with any of the following clinical condi-
tions: ocular infection (purulent drainage in the eye after
the sixth day of delivery), umbilical infection (foul smell
with periumbilical erythema), skin infection (cellulitis or
impetigo), lower or upper respiratory tract infection,
intestinal infection, meningitis or sepsis.
A puerperal outcome was positive when, during the first
month after delivery, a health care provider diagnosed the
women with any of the following: dehiscence of the epi-
siorraphy suture, purulent effusion from the episiorraphy,
urinary tract infection, pelvic inflammatory disease, or
vulvovaginitis.
The primary outcome of the study was an aggregated
maternal and neonatal infection rate: either the mother or
the newborn had an infectious outcome (combined infec-
tion rate) .
A team member visited participating women and new-
borns in hospital on a daily basis. Throughout the trial,
trained research assistants using standardised question-
naires, registered data from telephone calls, hospitalisa-
tions, follow-up visits, and any communications with the
participants, their families, or their health care providers.
Masking
Masking the use of enemas was unfeasible. However, we
made efforts to conceal the intervention by not separating
documents with information on the allocation from those
outcome data collection, by training the team's support-
ing clinical team (professional nurse, family medicine res-
idents, family medicine staff, and consulting
dermatologist) to avoid enquiring in ways that would
unmask the allocation. Health care providers in other set-
tings, such as physicians at emergency wards, paediatri-
cians and medics at outpatient clinics were unaware of the
allocation and frequently of the specific objectives of the
study. Except for the intervention, participants received
the same health care, and data retrievers would remain
unaware of individual allocations. Interventions
remained coded for the analysis and the code was broken
once the analysis was completed. Input between data at
recruitment and allocation was done weeks before the col-
lection of data on outcomes at follow up.
Sample size determination
We were unable to find reliable data on the incidence of
baseline infection rates for puerperal women or newborns
so we did a pilot study to have base data that would allow
a good estimate of frequencies for sample size calcula-
tions. The pilot study, which included the first 44 partici-
pants of the control group, estimated the combined
infection rate of puerperal women and newborns at 46
percent [7]. Using 5% significance and a 80% power, a
sample of 394 participants distributed in two parallel
groups was estimated to be required to detect a relative
difference of 25% in combined infection rates of women
and newborns, following the formulas provided by Dup-
pont and Plummer[8]. Assuming 4% of the participants
would be lost to follow-up, an estimated total sample of
410 women was required.
Data management and analysis
The database created in Epi-Info v 6.04 b was fed using
double data entry and transferred to Stata 5.0© using Stata
Transfer 4.0©. A Shapiro-Wilk test was used to determine if
the distribution of continuous variables was normal.
Non-normal distributions were transformed using a log
transformation, and if the distribution was persistently
non-normal, a Mann-Whitney test was used to compare
groups. Bivariate analyses were done using the chi-square
test or Fisher's exact test. Power calculations were done
using specialized software developed at the Clinical Epi-
demiology Unit at the Javeriana University[9].
Results
During the twelve months recruitment period (Feb 1997–
Feb 1998) 3170 women were admitted for delivery to the
obstetric service. The caesarean section rate in the obstet-
rics service was 26% at the time.BMC Pregnancy and Childbirth 2006, 6:8 http://www.biomedcentral.com/1471-2393/6/8
Page 4 of 6
(page number not for citation purposes)
Of the 460 women interviewed for recruitment, 16 were
non-eligible and 1 declined to participate. We ran-
domised 443 women (see Figure 1), among which we had
12 protocol violations; 4 in the enema group and 8 in the
control group. Nevertheless, these women were offered
the care and benefits that all other participants had. Pro-
tocol violations included admission with ruptured amni-
otic membranes (5 women in the control group),
infection at admission (1 in the control group, 2 in the
enema group). Five women didn't fulfil inclusion criteria
but were randomised (2 in the control group and 3 in the
enema group). The analysis for the remaining women was
done by group of allocation. Women who delivered by
caesarean section were considered in the analysis. Data
were not available to include in an 'intention to treat'
analysis the 12 women excluded because of violations to
the selection criteria (protocol violations).
Follow up was completed by 87% of the participating
women and 86% of newborns. Direct examination by a
team member at one month follow up was carried out in
20% of women and 19% of newborns (P = 0.51 and P =
0.98 respectively, with similar distribution between
groups); standardised telephone interviews with partici-
pants and healthcare providers allowed to assess out-
comes from the remaining participants.
Baseline characteristics were similar in both groups, sug-
gesting that randomisation provided well-balanced and
comparable groups (Table 1 [see additional file 2]).
Labour duration times and other maternal outcomes were
obtained from women's records after delivery and are pre-
sented in Table 2 [see Additional file 2]. Neonatal base-
line data obtained shortly after delivery from newborns'
records are summarised in Table 3 [see Additional file 2].
We found no statistically significant differences between
groups for labour duration, delivery types, episiotomy
rates, or prescription of antibiotics. Caesarean sections
were done in 12% of women with no significant differ-
ences in rates between groups.
No significant differences were found in the distribution
between groups for newborns' "Ballard" score, birth
weight, diagnosis of neonatal apnoea, or the administra-
tion of ocular and umbilical prophylaxis. Five newborns
allocated to the control group and none in the treatment
group developed respiratory tract infections, but this dif-
ference had no statistical significance. Two out of the five
newborns who developed lower respiratory tract infec-
tions were delivered by caesarean section. The three new-
borns with omphalitis belonged to the intervention
group, but again this difference was not statistically signif-
icant. Similarly, no significant differences were found for
ophthalmic infection rates, skin infections, intestinal
infections or the need for systemic antibiotics (Table 4
[see Additional file 2]).
No statistically significant differences were found for any
of the assessed outcomes in puerperal women. Pelvic
infections affected 4% of women: one was diagnosed with
myometrytis; five with endometritis; three had vul-
vovaginitis; and six had infected episiorraphy sutures. The
frequency and severity of perineal tear was similar in the
intervention and control group. No significant differences
were found in the rates of suture dehiscence among the
372 women who had epysiorraphy (Table 5 [see Addi-
tional file 2]).
Breast pain complaints were not categorised as an infec-
tious outcome and affected 31% of women, with 79% of
them suffering breast engorgement or nipple cracking and
no significant difference between groups (P = 0.75).
Summarised outcomes are provided in Table 6 [see Addi-
tional file 2]. Overall, one in five newborns had an infec-
tious outcome, and rates were not statistically significant
between groups. No significant differences were found for
aggregated maternal infections, although the study may
have been underpowered to rule out such differences; We
found an 8% absolute risk difference and a broad, skewed
confidence interval (see Table 6 [see Additional file 2]).
The aggregated outcome of "neonatal or puerperal infec-
tion" during the 30-day follow-up was higher in the con-
trol group than in the intervention group. However, the
6% difference in absolute risk can be due to chance (P =
0.23). Infections affecting both child and mother in the
same family were not significantly different (6/183 [3%]
with enema v 5/191 [3%] with no enema; P = 0.39).
We planned to assess the effect of enemas' on labour dura-
tion using multiple linear regression to adjust for parity.
However the normality test of the variable was rejected
and a Boxcox transformation (with a range between -2
and 2) did not provide an appropriate model. The residu-
als analysed through a robust regression had a non-nor-
mal distribution, so a non-parametric quintile regression
was done, finding no significant differences of labour
duration within study groups after adjusting for parity (P
= 0.07).
Participant flow and follow-up
Described in Figure 1 [see Additional file 1].
Discussion
Puerperal and neonatal infections, although seldom life
threatening, were very frequent in this study. Ophthalmic
infections were the most frequent infections amongst
newborns. Breast engorgement and nipple cracking wereBMC Pregnancy and Childbirth 2006, 6:8 http://www.biomedcentral.com/1471-2393/6/8
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the most frequent maternal complaints during puerper-
ium. Episiorraphy dehiscence was the most frequent
infectious outcome in women. We were impressed by
how frequent these outcomes were, and it is likely that
these problems are being missed in studies with a shorter
follow up, such as those that only follow women during
hospitalization. It also suggests that the follow up strategy
probably had a good sensitivity.
High volume enemas used during the first stage of labour
did not have a significant effect in the incidence of puer-
peral or neonatal infections, or labour duration. This RCT
found no significant differences in puerperal or neonatal
infection rates with enemas. No statistically significant
effects were found when analysing women or newborns
separately or when their outcomes were aggregated to ana-
lyse them as mother-newborn dyads.
The RCT had a power in excess of 80% to find differences
as big as 25% in the aggregated infection rates for women
and newborns. However, the study may have been under-
powered to detect differences for individual outcomes.
This RCT had an estimated power of 56% to find differ-
ences in neonatal infections, and 61% power to detect
puerperal infections. A higher rate of operative vaginal
deliveries was found in the enema group, although it did
not reach statistical significance. It is worth mentioning
this, because operative vaginal deliveries may have an
effect in puerperal infection rates. The use of an aggregated
outcome helped to reduce sample size but it would have
been ideal to have a sample size large enough to establish
effects in newborns and puerperal women separately.
Despite being practical, aggregating results has important
limitations: if the maternal and neonatal outcomes have
significantly different magnitudes or point out in different
directions, aggregation will cancelled out or underesti-
mate the differences.
We didn't have resources to collect information to assess
if the population of women admitted to the trial repre-
sented all eligible women. However, participation in the
trial was apparently determined by the commitment of
recruiters, not the participants' risk.
The RCT did not evaluate women's preferences or known
adverse effects of enemas, such as pain, discomfort,
embarrassment, or diarrhoea.
Since just one-fifth of the participants were personally
examined by trained research assistants at the one-month
assessment, measurements of these outcomes may have
been imprecise and could potentially disguise existing dif-
ferences, accounting for the lack of differences (risk of
Type II error). Nevertheless, significant misrepresenta-
tions of outcomes grave enough as to require hospitalisa-
tion, dedicated care, or urgent consultations are unlikely
with the follow up strategy we endorsed. Overall, partici-
pants and their families were helpful and willing to pro-
vide information; and we went to great efforts to use more
than one information source and verify abnormal results
in both women and neonates.
Conclusion
Puerperal and neonatal infections had high incidence
rates. Severe infections, such as myometritis and omphay-
litis, were unusual. In this study enemas didn't signifi-
cantly modify puerperal or neonatal infection rates. A
dramatically larger study would be necessary to determine
the effects, if any, of enemas on specific outcomes includ-
ing life-threatening complications. Enemas cause discom-
fort, increase workload for health carers and marginally
increase the cost of health care. At this time there is no
good evidence supporting the routine use of enemas. It
seems unlikely that the effect of enemas on the incidence
of specific outcomes is large enough to outweigh the
inconvenience or adverse effects associated to the routine
use of enemas during labour.
The data from this study combined from additional RCTs
may help better understand the particular effects of ene-
mas, guide policies and elucidate the role of enemas dur-
ing labour.
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